182 related articles for article (PubMed ID: 30897344)
41. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
[TBL] [Abstract][Full Text] [Related]
42. Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
Skill N; Wu J; Xu Y; Zhao Z; Maluccio M
Cancer Invest; 2013 Feb; 31(2):145-55. PubMed ID: 23362952
[TBL] [Abstract][Full Text] [Related]
43. Knockout of the Tachykinin Receptor 1 in the Mdr2
Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
[TBL] [Abstract][Full Text] [Related]
44. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
45. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
46. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
47. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
[TBL] [Abstract][Full Text] [Related]
48. Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks.
Barash H; R Gross E; Edrei Y; Ella E; Israel A; Cohen I; Corchia N; Ben-Moshe T; Pappo O; Pikarsky E; Goldenberg D; Shiloh Y; Galun E; Abramovitch R
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2207-12. PubMed ID: 20133864
[TBL] [Abstract][Full Text] [Related]
49. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
[TBL] [Abstract][Full Text] [Related]
50. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.
Chao X; Wang S; Hlobik M; Ballabio A; Ni HM; Ding WX
Am J Pathol; 2022 Jan; 192(1):87-103. PubMed ID: 34717896
[TBL] [Abstract][Full Text] [Related]
51. HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.
Hernandez C; Huebener P; Pradere JP; Antoine DJ; Friedman RA; Schwabe RF
J Clin Invest; 2018 Jun; 128(6):2436-2451. PubMed ID: 29558367
[TBL] [Abstract][Full Text] [Related]
52. Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis.
Hirsova P; Bohm F; Dohnalkova E; Nozickova B; Heikenwalder M; Gores GJ; Weber A
Cell Death Dis; 2020 Feb; 11(2):80. PubMed ID: 32015322
[TBL] [Abstract][Full Text] [Related]
53. Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
Uriarte I; Latasa MU; Carotti S; Fernandez-Barrena MG; Garcia-Irigoyen O; Elizalde M; Urtasun R; Vespasiani-Gentilucci U; Morini S; de Mingo A; Mari M; Corrales FJ; Prieto J; Berasain C; Avila MA
Int J Cancer; 2015 May; 136(10):2469-75. PubMed ID: 25346390
[TBL] [Abstract][Full Text] [Related]
54. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
55. Helicobacter hepaticus infection promotes hepatitis and preneoplastic foci in farnesoid X receptor (FXR) deficient mice.
Swennes AG; Sheh A; Parry NM; Muthupalani S; Lertpiriyapong K; García A; Fox JG
PLoS One; 2014; 9(9):e106764. PubMed ID: 25184625
[TBL] [Abstract][Full Text] [Related]
56. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.
Pusterla T; Nèmeth J; Stein I; Wiechert L; Knigin D; Marhenke S; Longerich T; Kumar V; Arnold B; Vogel A; Bierhaus A; Pikarsky E; Hess J; Angel P
Hepatology; 2013 Jul; 58(1):363-73. PubMed ID: 23504974
[TBL] [Abstract][Full Text] [Related]
57. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis.
Teeter LD; Estes M; Chan JY; Atassi H; Sell S; Becker FF; Kuo MT
Mol Carcinog; 1993; 8(2):67-73. PubMed ID: 8104413
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Territo PR; Maluccio M; Riley AA; McCarthy BP; Fletcher J; Tann M; Saxena R; Skill NJ
BMC Med Imaging; 2015 May; 15():15. PubMed ID: 25981587
[TBL] [Abstract][Full Text] [Related]
59. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
60. Global analysis of DNA methylation in early-stage liver fibrosis.
Komatsu Y; Waku T; Iwasaki N; Ono W; Yamaguchi C; Yanagisawa J
BMC Med Genomics; 2012 Jan; 5():5. PubMed ID: 22281153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
